Howard Halpern
Analyst, Taglit Brothers
Replay available
Intellinetics, Inc. (AMEX: INLX) Q3 2025 earnings conference call, held 2025-11-12. Replay captured from the company's public earnings webcast.

Analyst, Taglit Brothers
Director of Investor Relations
Chief Financial Officer
President and Chief Executive Officer
Greetings and welcome to Intellimedic's third quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. Please note this conference is being recorded. I will now turn the conference over to Roger Grabner. Thank you, Roger. You may begin. Thank you, and good afternoon, everyone. I'm pleased to welcome you to the IntelliNetics 2025 third quarter conference call. Before we begin, I would like to remind listeners that during this conference call, conference made by management may include forward-looking statements regarding IntelliNetics that are not historical facts. The forward-looking statements are based on the current expectations and beliefs of management, and they are subject to risk and uncertainties that could cause such statements to differ materially from actual future events or results. IntelliNetics undertakes no duty to update any forward-looking statements. For more information about the factors that may cause actual results to differ materially from forward-looking statements, please refer to the press release issued today, as well as risk and uncertainties included in the section under the caption, Risk Factors in Management Discussion and Analysis of financial condition and results of operations, and a telemedic's annual report on Form 10-K or their quarterly report on Form 10-Q filed today. Also, please note that on the call today, management will discuss non-GAAP financial measures of adjusted EBITDA. Non-GAAP financial measures are not intended to be considered in isolation or as a substitute for results prepared in accordance with...